• 5X Protein Loading Buffer (Reducing): SDS-PAGE Guide

  2026-08-24

  5X Protein Loading Buffer (Reducing) provides a concentrated, reducing sample matrix for denaturation and protein molecular weight separation in conventional SDS-PAGE. It is appropriate when disulfide bond reduction is required, but should not be used for native, non-reducing, or structure-preserving analyses.

• Prednisone Assay Workflows for Immunology

  2026-08-24

  Prednisone is a synthetic corticosteroid for dissecting lymphocyte cell-cycle control, cytokine signaling, and apoptosis in immune-cell models. This workflow-centered guide combines practical solubility guidance with matrix-aware assay design inspired by recent LC–MS/MS research, helping researchers distinguish compound effects from preparation and sampling artifacts.

• VE-821 for Reproducible ATR Assays

  2026-08-23

  A scenario-based guide to using VE-821 (SKU A2521) in viability, proliferation, cytotoxicity, radiosensitization, and chemotherapy-sensitization assays. It connects ATR biology with practical solvent, timing, control, interpretation, and product-selection decisions.

• AG-126 in ERK Signaling and D2-MSN Research

  2026-08-22

  AG-126 (Tyrphostin AG-126) provides a practical pharmacological tool for testing whether ERK1/2 signaling contributes to neuronal excitability, cytokine responses, or circuit-level phenotypes. This workflow connects phospho-ERK assays with D2-MSN models while clearly separating established evidence from hypothesis-generating applications.

• DHEA Workflows for Ovarian and Neural Research

  2026-08-22

  Build reproducible DHEA assays for granulosa cell proliferation, apoptosis inhibition, and neuronal survival with concentration and solvent controls that reduce common failure points. A recent premature ovarian insufficiency study provides a practical ER-stress framework for testing DHEA without overstating evidence from a different compound.

• InstaBlue Protein Stain Solution: Practical Protocol

  2026-08-21

  InstaBlue Protein Stain Solution provides rapid Coomassie staining of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and workflows that may proceed to mass spectrometry, but staining performance should be validated for each gel system and should not be treated as a stand-alone quantitative assay.

• Optimized hiPSC Platelet Differentiation: Study Analysis

  2026-08-20

  Yue and colleagues developed an optimized differentiation scheme that improves megakaryocyte generation and platelet production from human induced pluripotent stem cells by combining higher embryoid-body input, human platelet lysate, and small-molecule substitutions for selected cytokines. The 19-day workflow produced 14.9 platelets per input iPSC, supported thrombin-responsive clot formation, and reduced reported production costs by 58.3%, although further validation is needed for scale-up and clinical translation.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-20

  FITC-Concanavalin A is a fluorescent lectin conjugate for visualizing accessible α-D-glucose- and α-D-mannose-containing glycoconjugates on cells and tissues. It is appropriate for immunofluorescence staining, flow cytometry carbohydrate analysis, and related glycobiology workflows, but it should not be used to identify non-carbohydrate targets or under conditions that remove the calcium and manganese required for binding.

• Caspase-3 Colorimetric Assay Kit: Practical Guide

  2026-08-19

  The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a plate-based method for measuring DEVD-dependent caspase-3 activity through p-nitroaniline release. It is suitable for in vitro lysate-based apoptosis assays and related research, but it should not be treated as a standalone diagnostic, in vivo imaging method, or definitive proof of exclusive caspase-3 activation.

• Rotigotine Workflows for Parkinson’s Disease Research

  2026-08-19

  Rotigotine is a dopamine D2/D3 receptor agonist that supports complementary cell, behavioral, neuroprotection, and lower-urinary-tract studies. This workflow emphasizes route-aware dosing, vehicle control, cystometry, and practical troubleshooting for more reproducible Parkinson’s disease research.

• DeferoxamineB Workflows for Iron-Stress Research

  2026-08-18

  DeferoxamineB gives cancer researchers a practical iron-chelation control for separating ferroptosis-related effects from broader oxidative-stress, apoptosis, and autophagy responses. This guide translates the reference study’s metabolic strategy into assay-ready workflows, formulation guidance, and troubleshooting decisions.

• Tiamulin PK/PD: From MIC to Safe Study Design

  2026-08-18

  Tiamulin (Thiamutilin) is examined through a PK/PD lens that connects ribosomal mechanism, Mycoplasma gallisepticum efficacy, assay design, and veterinary exposure control. This evidence-led guide distinguishes validated findings from exploratory anti-inflammatory applications.

• CK2 Phosphorylation Tunes Arabidopsis LOH2

  2026-08-17

  This 2025 study identifies CK2 phosphorylation as a post-translational switch that simultaneously increases Arabidopsis LOH2 ceramide synthase activity and accelerates its ubiquitin-dependent degradation. The resulting balance controls C16 ceramide production, salicylic acid accumulation, programmed cell death, and resistance to fungal and bacterial stress.

• E-64d Workflows for Calpain and Lysoptosis Research

  2026-08-17

  E-64d is a membrane-permeable cysteine protease inhibitor that helps researchers separate calpain- and cathepsin-dependent events from broader cell-death phenotypes. This practical guide covers intracellular dosing, lysoptosis-focused assay design, platelet and seizure-model applications, and troubleshooting strategies that improve mechanistic confidence.

• BCL9 Inhibition Reverses Checkpoint Resistance

  2026-08-16

  Feng and colleagues developed hydrocarbon-stapled peptides that disrupt the β-catenin–BCL9 transcriptional complex and suppress Wnt-driven tumor biology. The study further shows that pathway inhibition can remodel the tumor immune microenvironment by reducing regulatory T cells and increasing dendritic and cytotoxic T-cell responses, thereby improving sensitivity to PD-1 blockade.

8453 records 1/564 page Next 12345 下5页 Last page